UFP TECHNOLOGIES INC (UFPT) Form 8-K — Nov 3, 2026
UFP Technologies reported strong Q3 2026 results: net sales of $172.4 million, up 11.6% year over year including 11.1% organic growth, and net income of $20.6 million, up 25.8%. GAAP diluted EPS was $2.64 versus $2.11 a year ago, with adjusted EPS of $2.88. Profitability improved alongside growth: gross margin expanded to 29.4% from 27.7%, operating income rose 18.1% to $27.6 million, and adjusted EBITDA grew 15.3% to $35.4 million. MedTech sales grew 12.5% on broad-based demand, and year-to-date sales reached $500.6 million, up 10.3%.
Key figures
- Eps
- 2.64
- Revenue
- 172434000
- Net Income
- 20617000
- Total Debt
- 96000000
- Revenue Yoy
- 11.6%
- Total Assets
- 682635000
- Cash Position
- 20625000
- Ytd sales
- 500600000
- Ytd gaap eps
- 7.56
- Ytd net income
- 58963000
- Adjusted eps q3
- 2.88
- Gross margin q3
- 29.4%
- Ytd adjusted eps
- 8.28
- Ytd sales growth
- 10.3%
- Organic growth q3
- 11.1%
- Adjusted ebitda q3
- 35429000
- Operating income q3
- 27606000
- Gross margin q3 2025
- 27.7%
- Adjusted net income q3
- 22475000
- Medtech sales growth q3
- 12.5%
- Operating income growth q3
- 18.1%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.